Advanced Plant Pharmaceuticals Announces Licensing Opportunity.NEW YORK--(BUSINESS WIRE)--Feb. 11, 1998--Advanced Plant Pharmaceuticals Inc. (OTC Bulletin Board OTC Bulletin Board An electronic quotation listing of the bid and asked prices of OTC stocks that do not meet the requirements to be listed on the NASDAQ stock-listing system. : APPI APPI American Psychiatric Publishing, Inc. APPI American Psychiatric Publishing Inc. APPI American Psychiatric Press, Inc. APPI Atmospheric Pressure Photoionization APPI Advanced Peer-to-Peer Internetworking APPI Advanced Plant Pharmaceuticals Inc. ) announced today that they have begun negotiations with several large companies in the health-related market to license APPI's breakthrough technology. APPI intends to create a new category market in the pharmaceutical industry -- The "Whole Plant Pharmaceutical." APPI is the first company in the history of the United States “American history” redirects here. For the history of the continents, see History of the Americas. The United States of America is located in the middle of the North American continent, with Canada to the north and the United Mexican States to the south. to receive a commercial IND on a whole plant pharmaceutical. APPI has identified two markets in which it intends to focus on licensing its technologies. 1) The Ethical Pharmaceutical Drug Market 2) The Nutritional Market which, according to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. independent market research, was valued at over nine billion dollars for 1996 APPI's whole plant pharmaceutical technology are trade secret and patent pending processes by which to turn a whole plant into your best standardized pharmaceutical grade product. APPI is a company that develops innovative plant formulations and technology for clinical application. APPI has met FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. nutritional specifications for the marketing of its LoChol in the United States, and has received the first IND from the FDA for a whole plant pharmaceutical which has potential as an immunomodulator. The initial studies are focusing on patients infected with HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. , the virus that causes AIDS. CONTACT: Advanced Plant Pharmaceuticals Inc. Sam Berkowitz 212/532-8114 Investor Package Martin Clare |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion